Skip to content

What is the Tentami syndrome? Unraveling Temtamy Syndrome

4 min read

Affecting fewer than one in a million people, what is often searched for as Tentami syndrome is actually known in the medical community as Temtamy syndrome. This extremely rare congenital genetic neurological disorder is characterized by a range of developmental and physical abnormalities, including the partial or complete absence of the corpus callosum, the main nerve fiber bundle connecting the brain's two hemispheres.

Quick Summary

Temtamy syndrome is a rare genetic neurological disorder caused by mutations in the C12orf57 gene. It is characterized by the underdevelopment of the corpus callosum and other severe congenital abnormalities affecting neurological function, eyes, craniofacial structure, and development.

Key Points

  • Misspelling of Temtamy Syndrome: The term 'Tentami syndrome' is a common misspelling of Temtamy syndrome, a rare congenital genetic neurological disorder.

  • Genetic Origins: Temtamy syndrome is caused by mutations in the C12orf57 gene and is inherited in an autosomal recessive manner.

  • Core Brain Abnormalities: A key feature is the agenesis or hypoplasia of the corpus callosum, the nerve bundle connecting the brain's hemispheres.

  • Multisystemic Symptoms: The disorder can manifest in a wide range of issues, including severe developmental delay, intractable seizures, intellectual disability, and characteristic facial and eye anomalies.

  • Symptomatic Management Only: Currently, there is no cure for Temtamy syndrome, and treatment is focused on managing specific symptoms and providing supportive care.

  • Diagnosis Through Genetic Testing: Diagnosis relies on clinical signs, brain imaging like MRI, and is confirmed by genetic testing, such as whole exome sequencing.

  • Impact on Quality of Life: Prognosis and quality of life depend on the severity of the condition, with early, multidisciplinary intervention being crucial.

In This Article

Deciphering the Terminology: Tentami vs. Temtamy

Searches for “Tentami syndrome” point to a lesser-known but distinct medical condition called Temtamy syndrome. The name comes from Dr. S. Temtamy, who first described the condition in 1991. It is a congenital genetic disorder, meaning it is present at birth and caused by specific gene mutations. As with many rare diseases, it is not widely known, which can lead to misspellings in searches.

The Genetic Root of Temtamy Syndrome

Temtamy syndrome is caused by pathogenic variants, or mutations, in the C12orf57 gene. This gene's exact function is still under investigation, but it is believed to be critical for the proper development of the corpus callosum and the eye. The syndrome is inherited in an autosomal recessive pattern. This means that a child must inherit a copy of the mutated gene from both parents to be affected. If a child receives one normal gene and one mutated gene, they will not develop the syndrome but will be a carrier of the genetic mutation. This mode of inheritance explains why it is often found in higher concentrations within certain populations, such as those of Middle-Eastern Arab descent, where consanguineous marriages are more common.

Common Signs and Symptoms

Because Temtamy syndrome affects multiple systems in the body, its manifestations are highly variable, even among family members. Symptoms typically appear in the neonatal period or infancy. The most prominent features are related to the central nervous system, eyes, and skeletal structure.

Key clinical features of Temtamy syndrome include:

  • Neurological:
    • Agenesis or hypoplasia (partial or complete absence) of the corpus callosum.
    • Moderate to severe intellectual disability.
    • Global developmental delay, with delayed motor and cognitive milestones.
    • Seizures that are often difficult to control.
    • Autistic features, such as absent language or stereotypy.
    • Hypotonia (low muscle tone).
  • Ocular (Eye-related):
    • Microphthalmia (abnormally small eyes).
    • Coloboma of the iris, retina, or choroid, which is a hole in one of the eye's structures.
    • Hypertelorism (widely spaced eyes).
    • Iris abnormalities, such as the classic “keyhole” pupil caused by an iris coloboma.
  • Craniofacial (Head and Face):
    • Characteristic dysmorphic facial features.
    • Elongated face (dolichocephaly) and macrocephaly (large head).
    • Low-set ears and a prominent, often beaked, nose.
    • Micrognathia (small lower jaw).
  • Skeletal and Other:
    • Skeletal anomalies, such as brachydactyly (short fingers or toes) and pes planus (flat feet).
    • Connective tissue dysplasia, which can lead to cardiovascular issues like aortic dilatation.

Diagnosis of Temtamy Syndrome

The diagnosis process for Temtamy syndrome typically begins with a clinical evaluation of the presenting symptoms in an infant or young child. A detailed assessment of developmental milestones and physical features is performed. A key step is utilizing medical imaging to confirm neurological abnormalities.

  • Brain Imaging: An MRI is used to visualize the brain's structure. In affected individuals, it will reveal the agenesis or hypoplasia of the corpus callosum and may show other anomalies like thalamic hypoplasia.
  • Genetic Testing: Since the features of Temtamy syndrome overlap with other rare conditions, a definitive diagnosis is most often achieved through genetic testing. Whole exome sequencing is a common method, which looks for mutations in the C12orf57 gene.
  • Differential Diagnosis: Doctors must differentiate Temtamy syndrome from other rare genetic disorders with similar features, such as Aicardi syndrome, Walker-Warburg syndrome, or Timothy syndrome.

Management and Prognosis

As with many rare genetic disorders, there is no cure for Temtamy syndrome. Management is symptomatic and supportive, meaning it focuses on treating specific symptoms and improving the individual's quality of life. This requires a multidisciplinary approach involving various medical specialists.

Management strategies include:

  • Seizure Control: Anti-epileptic medications are used to manage intractable seizures.
  • Rehabilitative Therapies: Physical, occupational, and speech therapy can help with developmental delays and motor skills.
  • Ocular Management: Regular ophthalmologic care is necessary to manage eye problems and vision issues.
  • Cardiovascular Care: Monitoring and treating any heart defects or aortic issues is crucial.
  • Educational Support: Specialized educational programs can assist with intellectual and developmental challenges.

The prognosis depends heavily on the severity of the symptoms. While some individuals may have a high degree of intellectual disability and complex medical needs, early intervention and comprehensive support can greatly enhance quality of life. Families are also offered genetic counseling to understand the inheritance pattern and risks for future pregnancies.

Comparing Temtamy Syndrome to a Similar Condition (Timothy Syndrome)

To further clarify the nature of Temtamy syndrome and to illustrate the complexity of rare genetic diseases, here is a comparison with another condition that shares some similar, but ultimately distinct, features: Timothy syndrome.

Feature Temtamy Syndrome Timothy Syndrome (LQT8)
Genetic Cause Mutations in the C12orf57 gene. Mutations in the CACNA1C gene.
Inheritance Autosomal recessive pattern. Autosomal dominant pattern (often de novo mutations).
Key Characteristic Corpus callosum abnormalities and eye colobomas. Prolonged QT interval and cardiac arrhythmias.
Neurological Issues Intellectual disability, seizures, developmental delay. Autism spectrum disorders, intellectual disability, seizures.
Physical Features Dysmorphic facies, skeletal anomalies (brachydactyly), aortic dilation. Syndactyly (webbed fingers/toes), distinctive facial features.
Life Expectancy Variable depending on severity; no specific lifespan data given. Can be life-threatening in childhood due to cardiac issues.

Conclusion

While the term Tentami syndrome is a common misspelling, it directs attention to the very real and serious rare genetic disorder known as Temtamy syndrome. Caused by mutations in the C12orf57 gene, this autosomal recessive condition results in severe congenital neurological, ocular, and developmental issues. Although there is no cure, a multidisciplinary approach focusing on symptomatic management can provide significant support to affected individuals and their families. For those seeking more information, resources like the National Organization for Rare Disorders (NORD) offer reliable medical data on Temtamy syndrome.

For more detailed information, you can visit the National Institutes of Health (NIH) website for resources on Temtamy syndrome.

Frequently Asked Questions

No, Tentami syndrome is not a recognized medical term. It is a common misspelling of Temtamy syndrome, a rare congenital genetic disorder.

The primary cause of Temtamy syndrome is a mutation in the C12orf57 gene. It is an inherited disorder following an autosomal recessive pattern.

Key symptoms include agenesis or hypoplasia of the corpus callosum, moderate to severe intellectual disability, developmental delay, seizures, eye abnormalities (coloboma, microphthalmia), and distinctive facial features.

Diagnosis is made based on clinical observation of symptoms, brain imaging (MRI) to detect corpus callosum abnormalities, and is confirmed through genetic testing, such as whole exome sequencing.

No, currently there is no cure for Temtamy syndrome. Treatment focuses on managing the specific symptoms and providing supportive care.

Management is symptomatic and supportive, and may include seizure medication, rehabilitative therapies (physical, occupational, speech), ocular care, cardiovascular monitoring, and special education.

The prognosis is highly variable and depends on the severity of the symptoms. While there is no cure, early and comprehensive intervention can significantly improve an individual's quality of life.

Yes, it is sometimes referred to as Temtamy-Shalash syndrome or craniofacial dysmorphism-coloboma-corpus callosum agenesis syndrome.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.